(...)... The deal covers the exclusive development and commercialisation rights for all oncology indications in China for PAT-SC1. Patrys will receive an upfront payment at that time and retains the right to develop and commercialise PAT-SC1 outside of China...(...)
on the other hand if you read that bit from Patrys website it says ALL oncology indications...so it may be leukemia? PAT-SC1 was for Gastric cancer and we had outstanding results (pure magic just about or miracle) and that is why I bought into it and loaded heaps (well, heaps for me).....lol...
wish they would hurry up with it...
PAB Price at posting:
1.9¢ Sentiment: Hold Disclosure: Held
